Lifeway Beats on Earnings, but Goes Free Cash Flow Negative
Analyst estimates are trumped, but the lack of cash profitability may be making investors nervous.
The Company is engaged in the manufacturing of probiotic, cultured, functional dairy and non-dairy health food products.
Analyst estimates are trumped, but the lack of cash profitability may be making investors nervous.
Kefir maker hikes annual payout by 14%.
$7.4 million purchase will quadruple Lifeway's production capacity.
Sales are going great guns, and free cash flow is gushing, but the valuation still nags.
For the first time in a long time, second-quarter results show signs of life.
There's some really smart folks up there.
Watch your step on the way down.
Market-trouncing returns could be written in this 4-Star.
It doesn't yet, but it's making an effort.
Not unless it can find something to buy.